JPWO2022102784A1 - - Google Patents

Info

Publication number
JPWO2022102784A1
JPWO2022102784A1 JP2022562229A JP2022562229A JPWO2022102784A1 JP WO2022102784 A1 JPWO2022102784 A1 JP WO2022102784A1 JP 2022562229 A JP2022562229 A JP 2022562229A JP 2022562229 A JP2022562229 A JP 2022562229A JP WO2022102784 A1 JPWO2022102784 A1 JP WO2022102784A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022562229A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022102784A1 publication Critical patent/JPWO2022102784A1/ja
Priority to JP2023138293A priority Critical patent/JP2023159401A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022562229A 2020-11-16 2021-11-16 Pending JPWO2022102784A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023138293A JP2023159401A (ja) 2020-11-16 2023-08-28 筋肉量の低下抑制に用いる細胞調製物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020190551 2020-11-16
PCT/JP2021/042028 WO2022102784A1 (ja) 2020-11-16 2021-11-16 筋肉量の低下抑制に用いる細胞調製物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023138293A Division JP2023159401A (ja) 2020-11-16 2023-08-28 筋肉量の低下抑制に用いる細胞調製物

Publications (1)

Publication Number Publication Date
JPWO2022102784A1 true JPWO2022102784A1 (ja) 2022-05-19

Family

ID=81601380

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022562229A Pending JPWO2022102784A1 (ja) 2020-11-16 2021-11-16
JP2023138293A Pending JP2023159401A (ja) 2020-11-16 2023-08-28 筋肉量の低下抑制に用いる細胞調製物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023138293A Pending JP2023159401A (ja) 2020-11-16 2023-08-28 筋肉量の低下抑制に用いる細胞調製物

Country Status (4)

Country Link
US (1) US20230321156A1 (ja)
EP (1) EP4245308A1 (ja)
JP (2) JPWO2022102784A1 (ja)
WO (1) WO2022102784A1 (ja)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017204231A1 (ja) * 2016-05-24 2017-11-30 国立大学法人 東京大学 臍帯由来細胞を含む脳障害の治療剤
JP2019514416A (ja) * 2016-05-16 2019-06-06 エグゾステム バイオテック リミテッド 間葉系幹細胞と筋損傷及び筋肉関連疾患の治療のための間葉系幹細胞の使用
JP2019535691A (ja) * 2016-11-03 2019-12-12 エグゾステム バイオテック リミテッド 間葉系幹細胞集団、それらの生成物およびそれらの使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6202672B2 (ja) 2013-10-04 2017-09-27 株式会社椿本チエイン 組織剥離防止プレートおよび培養ユニット
EP3738725B1 (en) 2019-05-15 2022-02-16 Omron Corporation Measurement system, measurement device, measurement method, and measurement program

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019514416A (ja) * 2016-05-16 2019-06-06 エグゾステム バイオテック リミテッド 間葉系幹細胞と筋損傷及び筋肉関連疾患の治療のための間葉系幹細胞の使用
WO2017204231A1 (ja) * 2016-05-24 2017-11-30 国立大学法人 東京大学 臍帯由来細胞を含む脳障害の治療剤
JP2019535691A (ja) * 2016-11-03 2019-12-12 エグゾステム バイオテック リミテッド 間葉系幹細胞集団、それらの生成物およびそれらの使用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF ORTHOPAEDIC TRANSLATION, vol. 23, JPN6023008264, 30 April 2020 (2020-04-30), pages 38 - 52, ISSN: 0005008755 *
MEDICAL SCIENCE MONITOR, vol. 24, JPN6023008265, 2018, pages 9272 - 9281, ISSN: 0005093424 *

Also Published As

Publication number Publication date
US20230321156A1 (en) 2023-10-12
EP4245308A1 (en) 2023-09-20
JP2023159401A (ja) 2023-10-31
WO2022102784A1 (ja) 2022-05-19

Similar Documents

Publication Publication Date Title
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
JPWO2023054317A1 (ja)
BR112023016292A2 (ja)
JPWO2022102784A1 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
JPWO2022180911A1 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016200A2 (ja)
BR102021016176A2 (ja)
BR102021015566A2 (ja)
BR102021015450A8 (ja)
BR102021015247A2 (ja)
BR102021015220A2 (ja)
BR102021014044A2 (ja)
BR102021014056A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230203

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230307

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230428

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230828

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230906

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20231006